Heart Disease Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Heart Attack
Drug-Eluting Stents Beat Bare Metal Stents in Diabetics
November 30th, 2008
Drug-eluting stents reduced the risk of revascularization, heart attack and death in diabetics as compared with bare-metal stents in the largest observational comparison, researchers reported at the American Heart Association's Scientific Sessions 2008. The results from The Drug-eluting and Bare Metal Stenting in Patients with Diabetes Mellitus: Results from the Mass-DAC Registry, were presented as a late-breaking clinical trial. The study is simultaneously published in Circulation: Journal of the American Heart Association. "We actually saw a significant benefit from using drug-eluting stents in this patient population," said Laura Mauri, M.D., M.Sc., principal...
Source: Heart Disease Weekly (2008-11-30)
|
